Acoustic Medsystems
Private Company
Total funding raised: $30M
Overview
Acoustic MedSystems is pioneering focused ultrasound technology for non-invasive therapeutic applications, primarily targeting soft tissue conditions and pain. Founded in 2009 and based in Champaign, Illinois, the company leverages image-guidance to deliver precise acoustic energy, aiming to offer alternatives to surgery or pharmaceutical interventions. As a private entity, it is likely in a development or early clinical stage, positioning itself in the growing market for minimally invasive treatments. Its success hinges on clinical validation, regulatory clearance, and eventual commercialization of its platform.
Technology Platform
Image-guided, minimally and non-invasive focused ultrasound platform for targeted soft tissue therapy and ablation.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Acoustic MedSystems competes in the focused ultrasound therapeutic space against public companies like Insightec (MRI-guided FUS) and Profound Medical (MRI-guided TULSA), as well as divisions of large device makers (e.g., Philips, Siemens Healthineers). In specific applications like cardiac ablation, it faces entrenched competition from electrophysiology giants such as Medtronic, Johnson & Johnson (Biosense Webster), and Boston Scientific. Its differentiation hinges on the specifics of its image-guidance approach, transducer design, and procedural workflow.